Back to search
Osteoporosis Secondary
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Osteoporosis Secondary trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Osteoporosis Secondary trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
A randomized controlled trial to evaluate AGN1 to prevent secondary hip fractures in osteoporotic women undergoing treatment of index hip fractures. Up to 2400…
Survival after breast cancer has increased due to early diagnosis and advances in treatment methods. Musculoskeletal problems related to cancer and its treatmen…
In women with breast cancer undergoing adjuvant hormone therapy, the marked tissue hypoestrogenism induced by therapy with aromatase inhibitors and/or tamoxifen…
This study aims to integrate bone measurements (including bone turnover markers (BTM), bone mineral density (BMD) measurement, vertebral fracture assessment (VF…
1. To Compare overall rates of second hip fractures in both genders, 2. To determine the effect of hip fracture on proximal femoral volumetric bone mineral dens…
With the aging of the world population, osteoporosis and fragility fractures have become global public health concerns. It has been estimated the population of…
Previously the approach to treatment of osteoporosis has been to use medications which prevent excessive resorption of bone. More recently medications that buil…
Previous studies have shown that there is a large inter-individual variability in the degree of bone loss during glucocorticoid treatment, and while some patien…